IGF-1 DES is a form of insulin-like growth factor-1 (IGF-1). In this peptide, the N-terminal sequence comprising Glycine-Proline-Glutamine is missing, assisting it in its potential to be resistant to certain inhibitors, and increasing its bioavailability. It is reported to exhibit a ten times greater potency than the untruncated version, with roles in hypertrophy and cellular growth research. The researchers report that “The increased potency is retained in part when the variant is administered in vivo, with selective anabolic effects particularly evident in gut tissues.” It also appears to induce anabolism in catabolic conditions such as those seen during chronic illnesses, as an anti-inflammatory agent against inflammatory bowel disease (IBD), and also certain neurological and neurodevelopmental disorders like autism.
Benefits:
Dosage:
40-50 mcg/day for men
10-20 mcg/day for women
